-
1
-
-
66749098832
-
Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis
-
Iozzo R.V., Zoeller J.J., Nystrom A. Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis. Mol Cells 2009, 27:503-513.
-
(2009)
Mol Cells
, vol.27
, pp. 503-513
-
-
Iozzo, R.V.1
Zoeller, J.J.2
Nystrom, A.3
-
2
-
-
0031657808
-
Matrix proteoglycans: from molecular design to cellular function
-
Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998, 67:609-652.
-
(1998)
Annu Rev Biochem
, vol.67
, pp. 609-652
-
-
Iozzo, R.V.1
-
4
-
-
0037178732
-
Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice
-
Costell M., Carmona R., Gustafsson E., et al. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 2002, 91:158-164.
-
(2002)
Circ Res
, vol.91
, pp. 158-164
-
-
Costell, M.1
Carmona, R.2
Gustafsson, E.3
-
5
-
-
0028072345
-
Abnormal expression of perlecan proteoglycan in metastatic melanomas
-
Cohen I.R., Murdoch A.D., Naso M.F., et al. Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res 1994, 54:5771-5774.
-
(1994)
Cancer Res
, vol.54
, pp. 5771-5774
-
-
Cohen, I.R.1
Murdoch, A.D.2
Naso, M.F.3
-
6
-
-
3643129096
-
Antisense targeting of perlecan blocks tumor growth and angiogenesis invivo
-
Sharma B., Handler M., Eichstetter I., et al. Antisense targeting of perlecan blocks tumor growth and angiogenesis invivo. JClin Invest 1998, 102:1599-1608.
-
(1998)
JClin Invest
, vol.102
, pp. 1599-1608
-
-
Sharma, B.1
Handler, M.2
Eichstetter, I.3
-
7
-
-
0028579734
-
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis
-
Aviezer D., Hecht D., Safran M., et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994, 79:1005-1013.
-
(1994)
Cell
, vol.79
, pp. 1005-1013
-
-
Aviezer, D.1
Hecht, D.2
Safran, M.3
-
8
-
-
27744523670
-
Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses invitro and tumor growth invivo
-
Savore C., Zhang C., Muir C., et al. Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses invitro and tumor growth invivo. Clin Exp Metastasis 2005, 22:377-390.
-
(2005)
Clin Exp Metastasis
, vol.22
, pp. 377-390
-
-
Savore, C.1
Zhang, C.2
Muir, C.3
-
10
-
-
0030010512
-
Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function
-
Iozzo R.V., Murdoch A.D. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 1996, 10:598-614.
-
(1996)
FASEB J
, vol.10
, pp. 598-614
-
-
Iozzo, R.V.1
Murdoch, A.D.2
-
11
-
-
40749125285
-
Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation
-
Kadenhe-Chiweshe A., Papa J., McCrudden K.W., et al. Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Mol Cancer Res 2008, 6:1-9.
-
(2008)
Mol Cancer Res
, vol.6
, pp. 1-9
-
-
Kadenhe-Chiweshe, A.1
Papa, J.2
McCrudden, K.W.3
-
12
-
-
3142682314
-
Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice
-
Zhou Z., Wang J., Cao R., et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res 2004, 64:4699-4702.
-
(2004)
Cancer Res
, vol.64
, pp. 4699-4702
-
-
Zhou, Z.1
Wang, J.2
Cao, R.3
-
13
-
-
1542283679
-
Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan
-
Tran P.K., Tran-Lundmark K., Soininen R., et al. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ Res 2004, 94:550-558.
-
(2004)
Circ Res
, vol.94
, pp. 550-558
-
-
Tran, P.K.1
Tran-Lundmark, K.2
Soininen, R.3
-
14
-
-
0037439268
-
Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney
-
Rossi M., Morita H., Sormunen R., et al. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J 2003, 22:236-245.
-
(2003)
EMBO J
, vol.22
, pp. 236-245
-
-
Rossi, M.1
Morita, H.2
Sormunen, R.3
-
16
-
-
73249140173
-
Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice
-
Sarkar K., Fox-Talbot K., Steenbergen C., Bosch-Marce M., Semenza G.L. Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci U S A 2009, 106:18769-18774.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 18769-18774
-
-
Sarkar, K.1
Fox-Talbot, K.2
Steenbergen, C.3
Bosch-Marce, M.4
Semenza, G.L.5
-
17
-
-
34548269646
-
Assessment of ischemia-induced microvascular remodeling using contrast-enhanced ultrasound vascular anatomic mapping
-
Pascotto M., Leong-Poi H., Kaufmann B., et al. Assessment of ischemia-induced microvascular remodeling using contrast-enhanced ultrasound vascular anatomic mapping. JAm Soc Echocardiogr 2007, 20:1100-1108.
-
(2007)
JAm Soc Echocardiogr
, vol.20
, pp. 1100-1108
-
-
Pascotto, M.1
Leong-Poi, H.2
Kaufmann, B.3
-
18
-
-
33750886289
-
Perlecan: how does one molecule do so many things?
-
Knox S.M., Whitelock J.M. Perlecan: how does one molecule do so many things?. Cell Mol Life Sci 2006, 63:2435-2445.
-
(2006)
Cell Mol Life Sci
, vol.63
, pp. 2435-2445
-
-
Knox, S.M.1
Whitelock, J.M.2
-
19
-
-
84872180918
-
Perlecan maintains microvessel integrity invivo and modulates their formation invitro
-
Gustafsson E., Almonte-Becerril M., Bloch W., Costell M. Perlecan maintains microvessel integrity invivo and modulates their formation invitro. PLoS One 2013, 8:e53715.
-
(2013)
PLoS One
, vol.8
, pp. e53715
-
-
Gustafsson, E.1
Almonte-Becerril, M.2
Bloch, W.3
Costell, M.4
-
20
-
-
77956641177
-
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
-
Theocharis A.D., Skandalis S.S., Tzanakakis G.N., Karamanos N.K. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 2010, 277:3904-3923.
-
(2010)
FEBS J
, vol.277
, pp. 3904-3923
-
-
Theocharis, A.D.1
Skandalis, S.S.2
Tzanakakis, G.N.3
Karamanos, N.K.4
-
21
-
-
78049344435
-
Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells
-
Muthusamy A., Cooper C.R., Gomes R.R. Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells. BMC Biochem 2010, 11:43.
-
(2010)
BMC Biochem
, vol.11
, pp. 43
-
-
Muthusamy, A.1
Cooper, C.R.2
Gomes, R.R.3
-
22
-
-
67649367545
-
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis
-
Zoeller J.J., Whitelock J.M., Iozzo R.V. Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis. Matrix Biol 2009, 28:284-291.
-
(2009)
Matrix Biol
, vol.28
, pp. 284-291
-
-
Zoeller, J.J.1
Whitelock, J.M.2
Iozzo, R.V.3
-
23
-
-
24744454378
-
Heparin regulates vascular endothelial growth factor 165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells
-
Ashikari-Handa S., Habuchi H., Kariya Y., Kimata K. Heparin regulates vascular endothelial growth factor 165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. JBiol Chem 2005, 280:31508-31515.
-
(2005)
JBiol Chem
, vol.280
, pp. 31508-31515
-
-
Ashikari-Handa, S.1
Habuchi, H.2
Kariya, Y.3
Kimata, K.4
-
24
-
-
57149114934
-
HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses
-
D'Souza S., Yang W., Marchetti D., Muir C., Farach-Carson M.C., Carson D.D. HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses. JCell Biochem 2008, 105:1183-1193.
-
(2008)
JCell Biochem
, vol.105
, pp. 1183-1193
-
-
D'Souza, S.1
Yang, W.2
Marchetti, D.3
Muir, C.4
Farach-Carson, M.C.5
Carson, D.D.6
-
25
-
-
0025765459
-
Altered distribution of basic fibroblast growth factor in diabetic retinopathy
-
Hanneken A., deJuan E., Lutty G.A., et al. Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalmol 1991, 109:1005-1011.
-
(1991)
Arch Ophthalmol
, vol.109
, pp. 1005-1011
-
-
Hanneken, A.1
deJuan, E.2
Lutty, G.A.3
-
26
-
-
0029851824
-
Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischemia and reperfusion in the rat
-
Ohira A., de Juan E., Tano Y., Wilson C.A. Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischemia and reperfusion in the rat. Histochem J 1996, 28:607-611.
-
(1996)
Histochem J
, vol.28
, pp. 607-611
-
-
Ohira, A.1
de Juan, E.2
Tano, Y.3
Wilson, C.A.4
-
27
-
-
0031659904
-
Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization
-
Ozaki H., Okamoto N., Ortega S., et al. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol 1998, 153:757-765.
-
(1998)
Am J Pathol
, vol.153
, pp. 757-765
-
-
Ozaki, H.1
Okamoto, N.2
Ortega, S.3
-
28
-
-
0031768434
-
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model
-
Tobe T., Ortega S., Luna J.D., et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998, 153:1641-1646.
-
(1998)
Am J Pathol
, vol.153
, pp. 1641-1646
-
-
Tobe, T.1
Ortega, S.2
Luna, J.D.3
-
29
-
-
0036892763
-
Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb
-
Sullivan C.J., Doetschman T., Hoying J.B. Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. JAppl Physiol 2002, 93:2009-2017.
-
(2002)
JAppl Physiol
, vol.93
, pp. 2009-2017
-
-
Sullivan, C.J.1
Doetschman, T.2
Hoying, J.B.3
|